ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $134,335 | -87.1% | 40,100 | -81.5% | 0.00% | -85.0% |
| Q4 2022 | $1,040,331 | -20.7% | 216,285 | -6.1% | 0.02% | -23.1% |
| Q3 2022 | $1,312,000 | +26.3% | 230,364 | +57.5% | 0.03% | +36.8% |
| Q2 2022 | $1,039,000 | -1.6% | 146,224 | +0.1% | 0.02% | +18.8% |
| Q1 2022 | $1,056,000 | +21.7% | 146,128 | +50.5% | 0.02% | +45.5% |
| Q4 2021 | $868,000 | -28.7% | 97,077 | +179.7% | 0.01% | -31.2% |
| Q3 2021 | $1,217,000 | – | 34,704 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |